Terms: = Gastric cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Prognosis
50 results:
1. Prognostic value of lymphocyte-to-monocyte ratio in gastric cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis.
Mei P; Feng W; Zhan Y; Guo X
Front Immunol; 2023; 14():1321584. PubMed ID: 38090560
[TBL] [Abstract] [Full Text] [Related]
2. B7-H3 and CD47 co-expression in gastric cancer is a predictor of poor prognosis and potential targets for future dual-targeting immunotherapy.
Chen S; Zhan S; Ding S; Zhang Q; Xuan H; Zhang X; Cao L
J Cancer Res Clin Oncol; 2023 Dec; 149(18):16609-16621. PubMed ID: 37715830
[TBL] [Abstract] [Full Text] [Related]
3. B7-H3 confers stemness characteristics to gastric cancer cells by promoting glutathione metabolism through AKT/pAKT/Nrf2 pathway.
Xia L; Chen Y; Li J; Wang J; Shen K; Zhao A; Jin H; Zhang G; Xi Q; Xia S; Shi T; Li R
Chin Med J (Engl); 2023 Aug; 136(16):1977-1989. PubMed ID: 37488673
[TBL] [Abstract] [Full Text] [Related]
4. The prognostic value of FAR and a novel FAR-CA125 score in resectable gastric signet ring cell carcinoma patients.
Shen Y; Li Y; Wang Z; Xu W; Wang W; Chen X
J Cancer Res Clin Oncol; 2023 Sep; 149(12):9597-9608. PubMed ID: 37222811
[TBL] [Abstract] [Full Text] [Related]
5. CD226 identifies functional CD8
Huang H; Huang Z; Ge J; Yang J; Chen J; Xu B; Wu S; Zheng X; Chen L; Zhang X; Jiang J
Front Immunol; 2023; 14():1150803. PubMed ID: 37056782
[TBL] [Abstract] [Full Text] [Related]
6. Microsatellite instability and sex-specific differences of survival in gastric cancer after neoadjuvant chemotherapy without and with taxane: An observational study in real world patients.
Hiltner T; Kohlruss M; Herz AL; Lorenzen S; Novotny A; Hapfelmeier A; Jesinghaus M; Slotta-Huspenina J; Sisic L; Gaida MM; Weichert W; Ott K; Keller G
J Cancer Res Clin Oncol; 2023 Aug; 149(10):7651-7662. PubMed ID: 37000259
[TBL] [Abstract] [Full Text] [Related]
7. Comprehensive analysis of immune subtypes reveals the prognostic value of cytotoxicity and FAP
Wang X; Hui S; Tan C; Deng Z; Wang X; Weng W; Zhang M; Ni S; Wang L; Huang D; Wang W; Xu M; Sheng W
Cancer Immunol Immunother; 2023 Jun; 72(6):1763-1778. PubMed ID: 36650362
[TBL] [Abstract] [Full Text] [Related]
8. Associations of patient-generated subjective global assessment (PG-SGA) and NUTRISCORE with survival in gastric cancer patients: timing matters, a retrospective cohort study.
Cho JW; Youn J; Kim EM; Choi MG; Lee JE
BMC Gastroenterol; 2022 Nov; 22(1):468. PubMed ID: 36396994
[TBL] [Abstract] [Full Text] [Related]
9. Identifying immune cells-related phenotype to predict immunotherapy and clinical outcome in gastric cancer.
Jiang S; Ding X; Wu Q; Cheng T; Xu M; Huang J
Front Immunol; 2022; 13():980986. PubMed ID: 36032097
[TBL] [Abstract] [Full Text] [Related]
10. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine Tumors.
Cai Y; Liu Z; Jiang L; Ma D; Zhou Z; Ju H; Zhu Y
Front Endocrinol (Lausanne); 2022; 13():871830. PubMed ID: 35937823
[TBL] [Abstract] [Full Text] [Related]
11. Multiplex immunohistochemistry defines the tumor immune microenvironment and immunotherapeutic outcome in CLDN18.2-positive gastric cancer.
Jia K; Chen Y; Sun Y; Hu Y; Jiao L; Ma J; Yuan J; Qi C; Li Y; Gong J; Gao J; Zhang X; Li J; Zhang C; Shen L
BMC Med; 2022 Jul; 20(1):223. PubMed ID: 35811317
[TBL] [Abstract] [Full Text] [Related]
12. Five EMT-related genes signature predicts overall survival and immune environment in microsatellite instability-high gastric cancer.
Zhang M; Cao C; Li X; Gu Q; Xu Y; Zhu Z; Xu D; Wei S; Chen H; Yang Y; Gao H; Yu L; Li J
Cancer Med; 2023 Jan; 12(2):2075-2088. PubMed ID: 35789544
[TBL] [Abstract] [Full Text] [Related]
13. Association of Adjuvant Chemotherapy With Overall Survival Among Patients With Locally Advanced gastric cancer After Neoadjuvant Chemotherapy.
Lin JX; Tang YH; Lin GJ; Ma YB; Desiderio J; Li P; Xie JW; Wang JB; Lu J; Chen QY; Cao LL; Lin M; Tu RH; Zheng CH; Parisi A; Truty MJ; Huang CM
JAMA Netw Open; 2022 Apr; 5(4):e225557. PubMed ID: 35363268
[TBL] [Abstract] [Full Text] [Related]
14. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
[No Abstract] [Full Text] [Related]
15. GARP Correlates With Tumor-Infiltrating T-Cells and Predicts the Outcome of gastric cancer.
Jiang S; Zhang Y; Zhang X; Lu B; Sun P; Wu Q; Ding X; Huang J
Front Immunol; 2021; 12():660397. PubMed ID: 34421887
[TBL] [Abstract] [Full Text] [Related]
16. Expression of the immune checkpoint receptors PD-1, LAG3, and TIM3 in the immune context of stage II and III gastric cancer by using single and chromogenic multiplex immunohistochemistry.
Park Y; Seo AN; Koh J; Nam SK; Kwak Y; Ahn SH; Park DJ; Kim HH; Lee HS
Oncoimmunology; 2021; 10(1):1954761. PubMed ID: 34367732
[TBL] [Abstract] [Full Text] [Related]
17. H. pylori negative gastric MALT lymphoma with api2-MALT1 translocation treated by endoscopic submucosal dissection: A case report.
Tahara T; Horiguchi N; Terada T; Yoshida D; Okubo M; Funasaka K; Nakagawa Y; Shibata T; Ohmiya N
Medicine (Baltimore); 2021 Apr; 100(14):e24371. PubMed ID: 33832060
[TBL] [Abstract] [Full Text] [Related]
18. [Safety and efficacy of adjuvant chemotherapy with oxaliplatin and S-1 for patients with locally advanced gastric cancer after D2 lymph nodes dissection].
Bao YD; Zhang H; Dong L; Jiang KW; Ye YJ; Wang S; Zhou J
Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):145-152. PubMed ID: 33508920
[No Abstract] [Full Text] [Related]
19. Identifying of biomarkers associated with gastric cancer based on 11 topological analysis methods of CytoHubba.
Ma H; He Z; Chen J; Zhang X; Song P
Sci Rep; 2021 Jan; 11(1):1331. PubMed ID: 33446695
[TBL] [Abstract] [Full Text] [Related]
20. A systematic review of microRNAs as potential biomarkers for diagnosis and prognosis of gastric cancer.
Ahadi A
Immunogenetics; 2021 Apr; 73(2):155-161. PubMed ID: 33399935
[TBL] [Abstract] [Full Text] [Related]
[Next]